Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$13,187,445
+$2,621,347 QoQ
Shares Held
52,406
+7.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#785
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fulton Bank, N.A. holds $64,915,903 across 12 Drug Manufacturers - General names. ABBV ranks #2 (20.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,349 | $17,210,622 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
52,406 | $13,187,445 | |
| 3 | MRK |
Merck & Co., Inc.
|
80,029 | $10,283,726 | |
| 4 | JNJ |
Johnson & Johnson
|
32,005 | $8,128,309 | |
| 5 | AMGN |
Amgen Inc
|
14,713 | $5,327,871 | |
| 6 | PFE |
Pfizer Inc
|
128,183 | $3,086,646 | |
| 7 | SNY |
Sanofi
|
68,196 | $2,909,240 | |
| 8 | AZN |
Astrazeneca PLC
|
8,294 | $1,572,707 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,187,445 | 52,406 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $10,566,098 | 48,582 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $10,758,680 | 47,086 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $11,571,905 | 49,978 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $9,548,849 | 51,443 | Shares | Sole | 2025-07-10 | |
| 2025-03-31 | $10,870,525 | 51,883 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $9,429,116 | 53,062 | Shares | Sole | 2025-01-08 | |
| 2024-09-30 | $9,421,967 | 47,711 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $8,230,730 | 47,987 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $7,889,664 | 43,326 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $6,959,082 | 44,906 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $6,370,227 | 42,736 | Shares | Sole | 2023-10-04 | |
| 2023-06-30 | $5,705,814 | 42,350 | Shares | Sole | 2023-07-06 | |
| 2023-03-31 | $6,943,112 | 43,566 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $7,267,762 | 44,971 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $6,281,564 | 46,804 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $7,220,727 | 47,145 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $9,456,523 | 58,334 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $9,165,090 | 67,689 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $7,367,305 | 68,298 | Shares | Sole | 2021-10-05 | |
| 2021-06-30 | $7,946,300 | 70,546 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $7,754,936 | 71,659 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $7,700,227 | 71,864 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $6,281,166 | 71,711 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $7,535,019 | 76,747 | Shares | Sole | 2020-07-06 | |
| 2020-03-31 | $5,978,476 | 78,468 | Shares | Sole | 2020-04-03 | |
| No filing history on record for this holder in this stock. | ||||||